TONMYA demonstrated significant reduction in fibromyalgia pain compared with placebo in the Phase 3 RESILIENT study. Unique sublingual formulation designed for bedtime dosing bypa ...

Neurologists participating in the survey also reported growing dissatisfaction with available treatment options as Parkinson’s disease progresses. Physicians estimated that approximately 45% of their ...

A new genetic and clinical analysis suggests that atypical depression represents a distinct biological subtype of the ...

DENVER, CO / ACCESS Newswire / January 20, 2026 / Aytu BioPharma, Inc. (the "Company" or "Aytu") (Nasdaq:AYTU), a pharmaceutical company focused on advancing innovative medicines for complex central ...

Addition of stereotactic body radiotherapy (SBRT) to systemic chemotherapy in locally advanced cholangiocarcinoma (CC) (ABC-07): Results from a randomized phase II trial. Efficacy of disitamab vedotin ...